GoAI
Get started
AK Medical Holdings Limited logo

AK Medical Holdings Limited

1789.HK

HKSEHealthcareMedical - Devices

Open in GoAI

Latest quote

HK$5.89

−HK$0.02 · -0.34%

Aug 24, 4:08 PM HKT

1789.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Industry
Medical - Devices
Sector
Healthcare
Headquarters
CN

Market position

Day range

Current HK$5.89

52-week range

Current HK$5.89

Open
HK$5.92
Previous close
HK$5.91
Volume
4.49M
Market cap
6.31B HKD
50-day average
HK$5.5505
+6.12% above average
200-day average
HK$5.9142
-0.41% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.5B CNY
P/E (TTM)
16.84×
P/B (TTM)
1.94×
P/S (TTM)
3.65×
EV / EBITDA
11.82×
Earnings yield
5.92%
Free cash flow yield
5.52%
Dividend yield
2.00%

Profitability & efficiency

Gross margin
60.54%
Operating margin
25.22%
Net margin
22.87%
Return on equity
11.64%
Return on assets
9.25%
Return on invested capital
10.41%

Financial health

Debt / equity
0.05×
Current ratio
4.1×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends71%50%28%7%Gross margin, FY2021: 65.56%Gross margin, FY2022: 60.49%Gross margin, FY2023: 61.66%Gross margin, FY2024: 60.03%Gross margin, FY2025: 60.54%Operating margin, FY2021: 13.06%Operating margin, FY2022: 20.91%Operating margin, FY2023: 19.33%Operating margin, FY2024: 22.34%Operating margin, FY2025: 25.22%Net margin, FY2021: 12.16%Net margin, FY2022: 19.46%Net margin, FY2023: 16.65%Net margin, FY2024: 20.35%Net margin, FY2025: 22.87%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 65.56%. Gross margin FY2022 60.49%. Gross margin FY2023 61.66%. Gross margin FY2024 60.03%. Gross margin FY2025 60.54%. Operating margin FY2021 13.06%. Operating margin FY2022 20.91%. Operating margin FY2023 19.33%. Operating margin FY2024 22.34%. Operating margin FY2025 25.22%. Net margin FY2021 12.16%. Net margin FY2022 19.46%. Net margin FY2023 16.65%. Net margin FY2024 20.35%. Net margin FY2025 22.87%.

Income trends

Revenue

1.48B CNY+10.11%

Operating income

373.88M CNY+24.30%

Net income

339.09M CNY+23.79%
Income trends across reported periods1.62B CNY1.07B CNY509.57M CNY−46.36M CNYRevenue, FY2021: 761.44M CNYRevenue, FY2022: 1.05B CNYRevenue, FY2023: 1.09B CNYRevenue, FY2024: 1.35B CNYRevenue, FY2025: 1.48B CNYOperating income, FY2021: 99.44M CNYOperating income, FY2022: 219.98M CNYOperating income, FY2023: 211.48M CNYOperating income, FY2024: 300.78M CNYOperating income, FY2025: 373.88M CNYNet income, FY2021: 92.62M CNYNet income, FY2022: 204.77M CNYNet income, FY2023: 182.1M CNYNet income, FY2024: 273.93M CNYNet income, FY2025: 339.09M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 761.44M CNY. Revenue FY2022 1.05B CNY. Revenue FY2023 1.09B CNY. Revenue FY2024 1.35B CNY. Revenue FY2025 1.48B CNY. Operating income FY2021 99.44M CNY. Operating income FY2022 219.98M CNY. Operating income FY2023 211.48M CNY. Operating income FY2024 300.78M CNY. Operating income FY2025 373.88M CNY. Net income FY2021 92.62M CNY. Net income FY2022 204.77M CNY. Net income FY2023 182.1M CNY. Net income FY2024 273.93M CNY. Net income FY2025 339.09M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue1.48B CNY1.35B CNY1.09B CNY1.05B CNY761.44M CNY
Cost of goods sold585.04M CNY538.18M CNY419.38M CNY415.61M CNY262.25M CNY
Gross profit897.4M CNY808.19M CNY674.49M CNY636.44M CNY499.19M CNY
Research and development141.64M CNY139.21M CNY137.13M CNY110.87M CNY113.07M CNY
Selling, general, and administrative417.58M CNY384.86M CNY352.25M CNY298.42M CNY292.66M CNY
Operating expenses523.52M CNY507.41M CNY463M CNY416.45M CNY399.75M CNY
Interest income29.39M CNY23.37M CNY22.77M CNY17.75M CNY8.99M CNY
Interest expense2.94M CNY923K CNY1.29M CNY2.17M CNY1.61M CNY
Depreciation and amortization91.45M CNY70.88M CNY90.94M CNY80.4M CNY74.16M CNY
Operating income373.88M CNY300.78M CNY211.48M CNY219.98M CNY99.44M CNY
Net income339.09M CNY273.93M CNY182.1M CNY204.77M CNY92.62M CNY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
60%
6 beats, 3 misses, 1 met estimate
Average EPS surprise
+7.92%
10 comparable reports
Latest EPS result
0.18
Estimate 0.17 · Beat by 6.71%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.240.170.110.04Q1 '23BeatQ3 '23BeatQ1 '24MissQ3 '24BeatQ1 '25BeatQ3 '25MetQ1 '26BeatQ3 '26Estimate
Q1 2023, reported Mar 28, 2023: actual 0.079, estimate 0.06, surprise +31.45%, Beat. Q3 2023, reported Aug 22, 2023: actual 0.134, estimate 0.119, surprise +12.53%, Beat. Q1 2024, reported Mar 26, 2024: actual 0.048, estimate 0.055, surprise -12.72%, Miss. Q3 2024, reported Aug 29, 2024: actual 0.135, estimate 0.129, surprise +4.58%, Beat. Q1 2025, reported Mar 25, 2025: actual 0.128, estimate 0.128, surprise +0.23%, Beat. Q3 2025, reported Aug 27, 2025: actual 0.153, estimate 0.153, surprise 0.00%, Met estimate. Q1 2026, reported Mar 25, 2026: actual 0.178, estimate 0.167, surprise +6.71%, Beat. Q3 2026, reported Aug 26, 2026: actual —, estimate 0.196, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates946.85M768.16M589.47M410.78MQ1 '23MissQ3 '23BeatQ1 '24BeatQ3 '24BeatQ1 '25MissQ3 '25MissQ1 '26MissQ3 '26Estimate
Q1 2023, reported Mar 28, 2023: actual 584.46M HKD, estimate 594.56M HKD, surprise -1.70%, Miss. Q3 2023, reported Aug 22, 2023: actual 733.01M HKD, estimate 688.78M HKD, surprise +6.42%, Beat. Q1 2024, reported Mar 26, 2024: actual 482.04M HKD, estimate 447.75M HKD, surprise +7.66%, Beat. Q3 2024, reported Aug 29, 2024: actual 711.3M HKD, estimate 701.89M HKD, surprise +1.34%, Beat. Q1 2025, reported Mar 25, 2025: actual 733.25M HKD, estimate 742.83M HKD, surprise -1.29%, Miss. Q3 2025, reported Aug 27, 2025: actual 760.73M HKD, estimate 774.06M HKD, surprise -1.72%, Miss. Q1 2026, reported Mar 25, 2026: actual 877.18M HKD, estimate 909.88M HKD, surprise -3.59%, Miss. Q3 2026, reported Aug 26, 2026: actual —, estimate 885.14M HKD, surprise —, Comparison unavailable.

1789.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.7

-3.94%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.46

-3.61%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$221.4

-2.89%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.60

-4.71%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.06

-6.11%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$99.50

-2.83%

ETFs holding 1789.HK

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core MSCI Emerging Markets ETF logoiShares Core MSCI Emerging Markets ETFIEMG
Market value
5.47M
Weight
0.00%
AUM
160B USD
Expense ratio
0.09%
Price / 1D
$80.505-1.31%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
5.43M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.185-0.60%
Vanguard FTSE Emerging Markets ETF logoVanguard FTSE Emerging Markets ETFVWO
Market value
5.25M
Weight
0.00%
AUM
162.3B USD
Expense ratio
0.06%
Price / 1D
$59.95-0.83%
Avantis Emerging Markets Equity ETF logoAvantis Emerging Markets Equity ETFAVEM
Market value
1.2M
Weight
—
AUM
27.89B USD
Expense ratio
0.33%
Price / 1D
$93.07-1.24%
iShares Core MSCI Total International Stock ETF logoiShares Core MSCI Total International Stock ETFIXUS
Market value
930.19K
Weight
0.00%
AUM
60.91B USD
Expense ratio
0.07%
Price / 1D
$97.37-0.59%
Dimensional - Emerging Markets Core Equity 2 ETF logoDimensional - Emerging Markets Core Equity 2 ETFDFEM
Market value
568.36K
Weight
0.01%
AUM
9.49B USD
Expense ratio
0.39%
Price / 1D
$39.505-1.06%
Sophus Capital Emerging Market Small Cap ETF logoSophus Capital Emerging Market Small Cap ETFEMSC
Market value
560K
Weight
1.23%
AUM
44.38M USD
Expense ratio
0.85%
Price / 1D
$25.2292-0.07%
WisdomTree Emerging Markets SmallCap Dividend Fund logoWisdomTree Emerging Markets SmallCap Dividend FundDGS
Market value
452.14K
Weight
0.03%
AUM
1.74B USD
Expense ratio
0.58%
Price / 1D
$63.335-0.01%

Continue in GoAI

Research 1789.HK

research.disclaimer